Eagles trade for Jets CB Michael Carter II, bolstering their secondary depth for a title defense.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Eagles trade for Jets CB Michael Carter II, bolstering their secondary depth for a title defense.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.